EyePoint Pharmaceuticals | 3:首次持股声明-董事 Hassan Fred
EyePoint Pharmaceuticals | 4:持股变动声明-董事 Hassan Fred
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 4:持股变动声明-董事 DICICCO WENDY F
EyePoint Pharmaceuticals | 4:持股变动声明-董事 ANDO GORAN
EyePoint Pharmaceuticals | 4:持股变动声明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 4:持股变动声明-董事 Lurker Nancy
EyePoint Pharmaceuticals | EFFECT:其他
EyePoint Pharmaceuticals | S-8:员工福利计划证券登记
EyePoint Pharmaceuticals | S-3:特定交易注册声明
EyePoint Pharmaceuticals | 10-Q:2024财年二季报
EyePoint Pharmaceuticals | 8-K:EyePoint Pharmicals公布2024年第二季度财务业绩并重点介绍最近的公司发展
EyePoint Pharmaceuticals | 4:持股变动声明-董事 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股变动声明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股变动声明-高管 Duker Jay S.
EyePoint Pharmaceuticals | 4:持股变动声明-高管 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股变动声明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 4:持股变动声明-董事 ADAMIS ANTHONY P
EyePoint Pharmaceuticals | 8-K:重大事件
暂无数据